Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Title
Intervention Indication Therapeutic Area Year Actions
Rivaroxaban (Xarelto) in Combination with Aspirin for Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease Rivaroxaban (Xarelto; BAY 59-7939) Cardiovascular disease (CVD) Cardiovascular System 2017 View  |  Download
Romosozumab for osteoporosis in men Romosozumab (Evenity; AMG-785) Osteoporosis Musculoskeletal System 2017 View  |  Download
Romosozumab for postmenopausal osteoporosis Romosozumab (Evenity; AMG-785) Osteoporosis Musculoskeletal System 2017 View  |  Download
Rovalpituzumab tesirine for the treatment of relapsed or refractory small cell lung cancer Rovalpituzumab tesirine (SC16LD6.5; Rova-T) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2017 View  |  Download
SA-237 for neuromyelitis optica and neuromyelitis optica spectrum disorders Satralizumab (SA237; RG6168) Neuromyelitis optica , Neuromyelitis optica spectrum disorders Neurology , Ophthalmology 2017 View  |  Download
SAGE-547 for super-refractory status epilepticus Brexanolone (SAGE-547; Zulresso) Super-refractory status epilepticus (SRSE) Neurology 2017 View  |  Download
Seladelpar for primary biliary cirrhosis – second or subsequent line Seladelpar (MBX-8025; RWJ-800025) Primary biliary cholangitis (PBC) Hepatology 2017 View  |  Download
Setmelanotide for pro-opiomelanocortin deficiency obesity Setmelanotide (RM-493) Obesity due to pro-opiomelanocortin deficiency Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Sotagliflozin tablets as an adjuct therapy to insulin for Type 1 diabetes mellitus Sotagliflozin (Zynquista; SAR439954; LX4211) Type 1 diabetes Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Subcutaneous Tocilizumab (RoACTEMRA) With or Without Methotrexate for the Treatment of Inadequate Responders in Systemic Juvenile Idiopathic Arthritis Methotrexate (MTX; Otrexup; Vibex MTX; MQX-5902; methotrexate disodium; methotrexate sodium) , Tocilizumab (Actemra; R1569; RoActemra) Juvenile idiopathic arthritis Rheumatology 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications